UTRECHT, Netherlands (Reuters) - Dutchman Lars Boom will start Saturday's first stage of the Tour de France despite showing low levels of cortisol in a test on the eve of the race, his Astana team manager said.
Low levels of the hormone can be explained by the use of corticoids, anti-inflammatory drugs that are allowed out of competition but forbidden while racing unless a rider is granted a Therapeutic Use Exemption (TUE).
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!